Evaluating Modifiable and Non-Modifiable Risk Factors Associated with Mortality in Aspiration Pneumonia
Keywords:
Aspiration pneumonia, Mortality Risk, Early Antibiotics, Nutritional supportAbstract
Background:Aspiration pneumonia is a prevalent and potentially lethal condition, especially in high-risk and elderly patients. Identification of the key risk factors of aspiration pneumonia can enhance outcomes and can help in treatment. Objective:To assess both modifiable and non-modifiable factors of mortality in patients with aspiration pneumonia. Methodology:A retrospective analysis was performed on 55 patients in a District level health facility to determine the risk factors for mortality in patients with aspiration pneumonia (AP). Age, neurological disease, nutritional status (measured by serum albumin), functional status (measured by the Eastern Cooperative Oncology Group (ECOG) Performance Status), and Do-Not-Resuscitate (DNR) status were assessed for their impact. Intensive Care Unit (ICU) admission rates and hospital stay were also compared between survivors and non-survivors. Results:Older age and neurological illness were high non-modifiable risk factors. Hypoalbuminemia and poor ECOG performance were associated with increased mortality, and therefore represent possible sites for intervention. Early antibiotic treatment had a trend towards increased survival that was not significant. DNR orders were more frequent in non-survivors. ICU admissions and increased hospital stay were also more frequent and strongly associated with this group and represent a more severe course of illness. Conclusion:This study emphasizes that modifiable and non-modifiable factors both effect the outcomes in aspiration pneumonia. While neurological disease and age are unchangeable risks, timely intervention focusing on nutrition and physical status can enhance prognosis. The role of DNR orders highlights the importance of clearly defined care goals.References
Zambare KK, Thalkari AB. Overview on pathophysiology of pneumonia. Asian J Pharm Res. 2019;9(3):177-80. DOI: 10.5958/2231-5691.2019.00028.5.
DiBardino DM, Wunderink RG. Aspiration pneumonia: a review of modern trends. J Crit Care. 2015;30(1):40-8. DOI: 10.1016/j.jcrc.2014.07.011.
Hayashi M, Iwasaki T, Yamazaki Y, Takayasu H, Tateno H, Tazawa S, et al. Clinical features and outcomes of aspiration pneumonia compared with non-aspiration pneumonia: a retrospective cohort study. J. Infect. Chemother. 2014;20(7):436-42. DOI: 10.1016/j.jiac.2014.04.002.
Rodriguez AE, Restrepo MI. New perspectives in aspiration community acquired Pneumonia. Expert Rev. Clin. Pharmacol. 2019;12(10):991-1002. DOI: 10.1080/17512433.2019.1663730.
DeLegge MH. Aspiration pneumonia: incidence, mortality, and atâ€risk populations. J Parenter Enteral Nutr. 2002;26:S19-25. DOI: 10.1177/014860710202600604.
Kumar S. Assessment of nutritional status and its impact on outcome in elderly admitted with respiratory diseases in critical care unit (Doctoral dissertation, BLDE (Deemed to be University)). 2021.
Son YG, Shin J, Ryu HG. Pneumonitis and pneumonia after aspiration. J Dent Anesth Pain Med. 2017;17(1):1.
van der Maarel-Wierink CD, Vanobbergen JN, Bronkhorst EM, Schols JM, de Baat C. Risk factors for aspiration pneumonia in frail older people: a systematic literature review. J Am Med Dir Assoc. 2011;12(5):344-54. DOI: 10.1016/j.jamda.2010.12.099.
Kikawada M, Iwamoto T, Takasaki M. Aspiration and infection in the elderly: epidemiology, diagnosis and management. Drugs Aging. 2005 ;22:115-30. DOI: 10.2165/00002512-200522020-00003.
Kim H, Jo S, Lee JB, Jin Y, Jeong T, Yoon J, et al. Diagnostic performance of initial serum albumin level for predicting in -hospital mortality among aspiration pneumonia patients. Am J Emerg Med. 2018;36(1):5-11. DOI: 10.1016/j.ajem.2017.06.039.
Pieralli F, Vannucchi V, De Marzi G, Mancini A, Bacci F, Para O, et al. Performance status and in-hospital mortality of elderly patients with community acquired pneumonia. Intern Emerg Med. 2018 Jun;13(4):501-507. DOI: 10.1007/s11739-018-1822-1.
Won JH, Byun SJ, Oh BM, Park SJ, Seo HG. Risk and mortality of aspiration pneumonia in Parkinson’s disease: a nationwide database study. Sci. Rep. 2021;11(1):6597. DOI: 10.1038/s41598-021-86011-w.
Sarkar M, Sarkar J. Respiratory Involvement in Parkinson’s Disease. The Indian J Chest Dis Allied Sci. 2023;65(2).
Walkey AJ, Weinberg J, Wiener RS, Cooke CR, Lindenauer PK. Association of do-not-resuscitate orders and hospital mortality rate among patients with pneumonia. JAMA Intern. Med. 2016;176(1):97-104. DOI: 10.1001/jamainternmed.2015.6324.
Lanspa MJ, Jones BE, Brown SM, Dean NC. Mortality, morbidity, and disease severity of patients with aspiration pneumonia. J Hosp Med. 2013;8(2):83-90. DOI: 10.1002/jhm.1996.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Chest Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
